Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Patients With Type 2 Diabetes and Inadequate Glycemic Control ; Phase III Study

NCT01370707 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT01370707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01370707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Patients With Type 2 Diabetes and Inadequate Glycemic Control ; Phase III Study
Lead sponsor
HK inno.N Corporation
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
July 31, 2012
Enrollment
187 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus